FDA PCAC reviews 7 peptides in July. Read →

PeptideXpo

FOXO4-DRI (FOX-04)

D-retro-inverso FOXO4 / p53 interaction blocker · senolytic peptide

≥ 99.0%CAS 2460055-10-9Longevity Peptides

Overview

FOXO4-DRI is a D-retro-inverso peptide designed to block the FOXO4–p53 interaction, studied in cellular-senescence and senolytic research.

Specifications

CAS
2460055-10-9
Purity (HPLC)
≥ 99.0%
Common vial sizes
2 mg, 10 mg
MOQ
On request
Lead time
14–21 days
Storage
-20°C, protect from light

Documentation available on request

  • Certificate of Analysis (COA)
  • HPLC Chromatogram
  • Mass-spec spectrum
  • Stability data
  • SDS / MSDS
  • Sequence verification